U.S. Product Catalog
Methylphenidate Hydrochloride Extended-Release Tablets, USP
| Product Image | Product Name | ANDA# | Strength(s) | NDC Code | Package Size | Product Information |
|---|---|---|---|---|---|---|
 |
Methylphenidate Hydrochloride Extended-Release Tablets USP, 10 mg View Details | 210992 | 10 mg | 70010-042-01 | 100 | Prescribing Information Medication Guide |
 |
Methylphenidate Hydrochloride Extended-Release Tablets USP, 20 mg View Details | 210992 | 20 mg | 70010-043-01 | 100 | Prescribing Information Medication Guide |
Our differentiating edge
We strive to provide access to safe, effective and affordable medicines to the people who need them.
Here is how our key strengths help us achieve our objective.
BusinesAs model
An integrated value chain that has promoted us from an API manufacturer to a global pharmaceutical player.
Strong r&d capabilities
Our dedicated research& development team is committed to developing processes and products to create a diverse range of cost effective medicines for our customers.
Economies of scale
Our facilities can accommodate large-scale customers with our industry leading batch size in PFIs.
Regulatory compliance
Our manufacturing facilities are aligned with rigorous global operating benchmarks, approved by global regulatory authorities.
Commitment to quality manufacturing
Our multiple manufacturing facilities provide us with the flexibility to select the most appropriate manufacturing strategy for a particular product, taking into account factors such as cost, regulatory requirements and capacity.
Product basket
Our comprehensive product basket, comprising high-value and high-growth APIs, PFIs and Finished Dosages cater to the needs of global giants.